Pfizer Shareholder Suit Brought in New York over Bribery
After settling with the U.S. for $60 million, the company now faces a shareholder suit in New York saying its poor FCPA compliance damaged shareholder equity.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10